Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrafine vs fine particle inhaled combination therapy in asthma with small airway dysfunction
ChiCTR2000035336Phase 4Recruiting
- Sponsor
- Shanghai General Hospital
- Start
- Aug 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of beclomethasone, budesonide and formoterol in allergic asthma, cough variant asthma (CVA) and asthma (2 arms), sponsored by Shanghai General Hospital. Primary endpoints: FEV1, MMEF and 1 more. Started Aug 2020; status: recruiting.
02
Drugs
beclomethasonebudesonideformoterol
03
Conditions
allergic asthmacough variant asthma (CVA)asthma
Beyond the preview
Go deeper on ChiCTR2000035336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035336.